Devonian Health Group (CVE:GSD) Shareholders Received A Total Return Of 1231% In The Last Three Years

No-one enjoys it when they lose money on a stock. But it can difficult to make money in a declining market. The Devonian Health Group Inc. (CVE:GSD) is down 78% over three years, but the total shareholder return is 1231% once you include the dividend. That’s better than the market which declined 0.1% over the last three years. And more recent buyers are having a tough time too, with a drop of 48% in the last year. Even worse, it’s down 37% in about a month, which isn’t fun at all.

See our latest analysis for Devonian Health Group

Given that Devonian Health Group didn’t make a profit in the last twelve months, we’ll focus on revenue growth to form a quick view of its business development. Shareholders of unprofitable companies usually expect strong revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

More

It’s good to see that there was some significant insider buying in the last three months. That’s a positive. That said, we think earnings and revenue growth trends are even more important factors to consider. This free interactive report on Devonian Health Group’s earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

What about the Total Shareholder Return (TSR)?

We’ve already covered Devonian Health Group’s share price action, but we should also mention its total shareholder return (TSR). The TSR attempts to capture the value of dividends (as if they were reinvested) as well as any spin-offs or discounted capital raisings offered to shareholders. We note that Devonian Health Group’s TSR, at 1231% is higher than its share price return of -78%. When you consider it hasn’t been paying a dividend, this data suggests shareholders have benefitted from a spin-off, or had the opportunity to acquire attractively priced shares in a discounted capital raising.

A Different Perspective

Devonian Health Group shareholders are down 48% for the year, falling short of the market return. Meanwhile, the broader market slid about 8.9%, likely weighing on the stock. Fortunately the longer term story is brighter, with total returns averaging about 137% per year over three years. The recent sell-off could be an opportunity if the business remains sound, so it may be worth checking the fundamental data for signs of a long-term growth trend. It’s always interesting to track share price performance over the longer term. But to understand Devonian Health Group better, we need to consider many other factors. Take risks, for example – Devonian Health Group has 5 warning signs (and 3 which don’t sit too well with us) we think you should know about.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CA exchanges.

Love or hate this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected].

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Thank you for reading.